Latest filing published 14 Sept 2010 for KYTO BIOPHARMA INC.
No signal scores available.
Not enough history yet: 0 closed purchases, at least 2 are needed.
Filings by Credifinance Capital Corp. span 3 companies, the busiest being Osprey Gold Corp, Freedom Holding Corp. and Kyto Biopharma Inc. The record holds 17 filings, for trades running from 14 November 2005 to 2 September 2010.
Both buying and selling appear: 3 purchases worth €2.1M, against 2 sales worth €57k. Taken together, the purchases exceed the sales by €2.1M. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Besides market trades, the filings include 7 share grants. 2010 to date brings no purchases and 2 sales.
In size, the median ticket on the buying side is €179k.
The latest filing, published on 14 September 2010, reports a transaction in Osprey Gold Corp. The last purchase on record was published on 13 January 2006, which is 7,589 days ago. Filings reach the SEC (Form 4) feed a median of 12 days after the trade. US insiders must file a Form 4 within two business days of a trade. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
17 of 17 declarations